Biodesix announces publication of seminal PROSE study in the Lancet Oncology

13-05-2014 Business Wire HealthComments (0)

PharmaceuticalUSA

The Lancet publishes Biodesix's VeriStrat P3 trial results for non-small cell lung cancer

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top